Irbesartan
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65862-637 -
Package NDC
65862-637-05 -
Package NDC
65862-637-30 -
Package NDC
65862-637-78 -
Package NDC
65862-637-90 -
Application number
ANDA203081 -
SPL ID
9e17df53-3757-4012-a76f-d1aa0053fda0 -
SPL set ID
2113a901-2612-4557-b86d-3afc006fb8bb -
UNII
J0E2756Z7N -
RxCUI
200094 -
RxCUI
200095 -
RxCUI
200096
What the source publishes
- Labeler
- Aurobindo Pharma Limited
- Active ingredients
- Irbesartan
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Irbesartan",
"splId": "9e17df53-3757-4012-a76f-d1aa0053fda0",
"labels": [
{
"setId": "2113a901-2612-4557-b86d-3afc006fb8bb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2113a901-2612-4557-b86d-3afc006fb8bb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2113a901-2612-4557-b86d-3afc006fb8bb"
}
],
"routes": [
"ORAL"
],
"labeler": "Aurobindo Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (65862-637-05)",
"package_ndc": "65862-637-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20120927"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (65862-637-30)",
"package_ndc": "65862-637-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20120927"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (65862-637-78) / 10 TABLET in 1 BLISTER PACK (65862-637-10)",
"package_ndc": "65862-637-78",
"identifierStatus": "well-formed",
"marketing_start_date": "20140922"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (65862-637-90)",
"package_ndc": "65862-637-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20120927"
}
],
"productId": "65862-637_9e17df53-3757-4012-a76f-d1aa0053fda0",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "65862-637",
"deaSchedule": null,
"genericName": "Irbesartan",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "IRBESARTAN",
"strength": "75 mg/1"
}
],
"applicationNumber": "ANDA203081",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120927",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000070",
"N0000175561"
],
"upc": [
"0365862637901"
],
"unii": [
"J0E2756Z7N"
],
"rxcui": [
"200094",
"200095",
"200096"
],
"spl_set_id": [
"2113a901-2612-4557-b86d-3afc006fb8bb"
],
"pharm_class_epc": [
"Angiotensin 2 Receptor Blocker [EPC]"
],
"pharm_class_moa": [
"Angiotensin 2 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Aurobindo Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65862-637_9e17df53-3757-4012-a76f-d1aa0053fda0"